Non-penetrating glaucoma surgery using AquaFlow(TM)collagen implants.
AquaFlow TM is an absorbable collagen implant for use in non-penetrating surgery for primary open angle glaucoma. Its purpose is to facilitate drainage of fluid from the eye, thereby reducing intraocular pressure. AquaFlow TM is approved for use in Canada in medically refractory cases of primary open angle glaucoma. Non-penetrating glaucoma surgery with the AquaFlow TM implant appears to be a relatively safe procedure. However, there is a steep learning curve for the surgeon and it is initially associated with a high rate of conversion to conventional surgery during the operation. Limited evidence from small non-randomized trials suggests that the AquaFlow TM implant may offer benefits over conventional surgical approaches in terms of reduced complication rates, reduced medication use, an earlier return of improved vision and sustained control of intraocular pressure. However, the efficacy and cost-effectiveness of this approach have not been established. January, 2001 for use in patients with uncontrolled
Demeter
S
S
Hailey
D
D
D002170:Canada; D002983:Clinical Competence; D002986:Clinical Trials as Topic; D003094:Collagen; D003362:Cost-Benefit Analysis; D018795:Device Approval; D005902:Glaucoma, Open-Angle / Q000601:surgery*; D006801:Humans; D007429:Intraocular Pressure; D019919:Prosthesis Implantation / Q000379:methods; D012599:Sclerostomy; D014481:United States; D014486:United States Food and Drug Administration
D003094:Collagen